Share This

Public company info - Lepu Biopharma Co. Ltd. -H Shares , 02157.HK
Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

Lepu Biopharma Co. Ltd. -H Shares, 02157.HK - Cash Flow 2021-12 2020-12 2019-12
Net Cash Flow from Operating Activities -626,189 -427,919 -234,390
Net Cash Flow from Return on Investments & Servicing of Finance -4,838 -7,465 -297
　Interest Received 4,453 5,230 396
　Interest Paid -9,291 -12,695 -693
　Dividend Received 0 0 0
　Dividend Paid 0 0 0
　Others 0 0 0
Taxes (Paid) / Refunded 0 0 0
Net Cash Flow from Investing Activities -3,892 -749,669 -415,318
　Additions to Fixed Assets -213,385 -293,873 -318,471
　Disposal of Fixed Assets 0 771 0
　Increase in Investments -1,129,001 -1,702,175 -519,500
　Decrease in Investments 1,474,610 1,332,701 511,535
　Net Cash Flow with Related Parties 261,120 1,394,500 296,390
　Others -397,236 -1,481,593 -385,272
Net Cash Flow before Financing Activities -634,919 -1,185,053 -650,005
Net Cash Flow from Financing Activities 389,601 1,399,374 771,087
　New Loans 146,112 59,000 118,266
　Loans Repayment -15,815 -54,126 -1,685
　Fixed Income/Debt Instruments 0 0 358,116
　Repayment of Fixed Income/Debt Instruments 0 0 0
　Equity Financing 0 0 0
　Net Cash Flow with Related Parties 261,120 1,394,500 296,390
　Others -1,816 0 0
Increase(Decrease) in Cash & Cash Equivalents -245,318 214,321 121,082
Cash & Cash Equivalents at Beginning of Year 402,867 188,545 67,462
Net Cash Flow due to Change in Exchange Rate/Others -2,381 1 1
Cash & Cash Equivalents at End of Year 155,168 402,867 188,545
Currency Renminbi Renminbi Renminbi
Unit
Auditor's Opinion 1 0 0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.